Team
We are dedicated to improving the care of cancer patients through rapid on-site tissue imaging and artificial intelligence.
Jay Trautman, PhD
President & CEO, Co-Founder
30+ years in pharmaceutical, medical device and life-science R&D and commercialization
Co-founded 5 companies, 4 have exited
Vedere Bio acquired by Novartis for $280M; Praelux sold to Amersham/GE
Started career at Bell Labs
Chris Freudiger, PhD
Chief Technology Officer, Co-Founder
18+ years in biomedical and medical devices
World-renowned spectroscopist and artificial intelligence expert, 10k+ citations, 10+ artificial intelligence image analysis publications
Discovered SRH at Harvard, led engineering of the NIO Laser Imaging System and artificial intelligence, led early commercialization with KOLs
Steven Pastore, MD
VP of Clinical Affairs
5+ years in pathology and medical devices
Obtained MD at Zucker School of Medicine, completed 18 months of pathology residency at Northwell Health
Serves as SRH pathology expert, leads clinical studies, and liaison for commercialization and artificial intelligence development
Adrian Ion-Margineanu, Dual PhD
Head of Artificial Intelligence Development
10+ years in artificial intelligence/machine learning and biomedical imaging, dual PhD in Machine and Deep Learning
Marie Curie Fellow with 19 published and peer-reviewed papers on artificial intelligence/machine learning/deep learning, ex-Phillips where he developed deep learning algorithms for tumor cell detection in H&E and IHC microscopy images.
Leads artificial intelligence development at Invenio, developing AI for brain cancer (CE-marked), lung cancer, and prostate cancer
Geoff Maniago
Manager of Manufacturing
20+ years manufacturing and developing complex laser systems
Ex-Coherent (scientific & high power lasers) and Enablence Tech (telecom), experience in ISO-13485 quality systems
Leads in-house manufacturing of the NIO Laser Imaging System, 20+ systems completed